WuXi Biologics reports share repurchase

WuXi Biologics (HKEX:2269) announced the movement of securities for the month ended February 28, 2025, reporting the repurchase of 9,509,500 ordinary shares, although not yet cancelled by the end of the month. The filing also detailed movements in share options under pre-IPO schemes and restricted share award schemes, with a remaining authorized share capital of USD 50,000. The company reiterated that no further share options could be granted under the pre-IPO scheme after the company shares were listed. As of February 2025, the total number of issued shares remains at 4,107,040,045.